Aman Tedasen

6PUBLICATIONS
27CO-AUTHORS
Characterisation of biological macromoleculesMolecular medicineToxicology (incl. clinical toxicology)Biomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
6β-Acetoxysandaracopimaradien-1α,9α-diol Attenuates LPS-Induced Acute Lung Injury: Association with Alterations in Src, MAPK, and Akt/GSK-3β Signalling.

|Feb 12, 2026
Mechanistic insights into the anti-inflammatory effects of isocoronarin D associated with reduced PKCδ and PI3K/Akt signalling in LPS-activated macrophages.

Wanatsanan Chulrik, Rungruedee Kimseng, Chutima Jansakun

|Jan 21, 2026
In Silico Investigation Reveals IL-6 as a Key Target of Asiatic Acid in Osteoporosis: Insights from Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.

Wanatsanan Chulrik, Aman Tedasen, Nateelak Kooltheat

|Aug 12, 2025
Penicillium-Derived Inhibitors of Plasmodium falciparum Lactate Dehydrogenase (PfLDH): A Computational Approach for Novel Antimalarial Therapy Development.

Imran Sama-Ae, Pimthip Muengthongon, Azeezah Tohlaeh

|May 02, 2023
Protective effects of Stephania pierrei tuber-derived oxocrebanine against LPS-induced acute lung injury in mice.

Wanatsanan Chulrik, Chutima Jansakun, Waraluck Chaichompoo

|Jul 13, 2022
Oxocrebanine from Stephania pierrei exerts macrophage anti-inflammatory effects by downregulating the NF-κB, MAPK, and PI3K/Akt signalling pathways.

Wanatsanan Chulrik, Chutima Jansakun, Waraluck Chaichompoo

Pageof 1

Frequent Collaborators

5 joint publications

Wanatsanan Chulrik

4 joint publications

Chutima Jansakun

4 joint publications

Apichart Suksamrarn

4 joint publications

Warangkana Chunglok